சுருக்கம்
Clinical Oncology 2018: Development of PI3K inhibitor Copanlisib – New insights and outlook - Ningshu Liu - Bayer AG, Germany
Clinical Oncology 2018: Pseudo-relapse and cancer stem cells in ovarian cancer - Martin Orlando Rosas Delgado - Sonora Cancer Research Center (CICS Sonora), Mexico
Clinical Oncology 2018: Proton Therapy - The current situation - Karol Sikora - Proton Partners International Ltd, UK
Clinical Oncology 2018: Value of Ki67 in locally advanced breast cancer treated with neoadjuvant chemotherapy - Miral Mohammed Mashhour - King Fahad Specialist Hospital, Dammam, Saudi Arabia